Patents Assigned to Ceva Santé Animale
  • Oral solid dosage form of amlodipine and veterinary uses thereof
    Patent number: 11147804
    Abstract: The invention relates to the field of animal health. In particular, the invention relates to an oral solid dosage form comprising, as pharmaceutically active compounds, amlodipine. The invention relates to an oral solid dosage forms comprising an amlodipine besylate according to a particular posology for the treatment of hypertension in non-human mammal animals.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: October 19, 2021
    Assignee: CEVA SANTE ANIMALE
    Inventors: Romain Charles, Rosita Garcia
  • Compositions and uses thereof for controlling ectoparasites in non-human mammals
    Patent number: 11134685
    Abstract: The invention relates to novel veterinary compositions comprising an effective amount of a neonicotinoid compound and an effective amount of a N-arylpyrazole compound. The invention also relates to the use of such compositions for controlling ectoparasites in a non-human mammal.
    Type: Grant
    Filed: January 29, 2020
    Date of Patent: October 5, 2021
    Assignee: Ceva Santé Animale
    Inventors: Hamadi Karembe, Marie Varloud
  • Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
    Patent number: 11123425
    Abstract: The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein the at least two recombinant nucleotide sequences are inserted into distinct non-coding regions of the viral genome chosen among the region located between UL44 and UL45, the region located between UL45 and UL46, the region located between US10 and SORF3, and the region located between SORF3 and US2.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: September 21, 2021
    Assignee: CEVA SANTE ANIMALE
    Inventors: Ayumi Fujisawa, Mayumi Kubomura, Sakiko Saeki, Shuji Saito
  • Method for the treatment of valvular heart disease comprising administering a composition comprising sarpogrelate
    Patent number: 11116741
    Abstract: The present invention relates to the use of a serotoninergic receptor antagonist, such as sarpogrelate or compositions thereof, for the treatment and/or prevention of heart damages in mammals.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: September 14, 2021
    Assignee: CEVA SANTE ANIMALE
    Inventors: Estelle Ayme-Dietrich, Jérôme Guyonnet, Roland Lawson, Luc Maroteaux, Laurent Monassier
  • Palatable oral veterinary compositions
    Patent number: 11090270
    Abstract: The present invention is directed to palatable veterinary compositions made from one or more pharmaceutical active ingredients having a smell and/or a taste that is repulsive to animals, and a preparation method for preparing oral veterinary compositions. Various aspects of the present invention are related to preparing palatable veterinary compositions that comprises mixing one or more pharmaceutical active ingredients having a smell with one or more palatabilizing agents.
    Type: Grant
    Filed: January 29, 2020
    Date of Patent: August 17, 2021
    Assignee: Ceva Santé Animale
    Inventors: Laurence Peyrot, Florence Guimberteau
  • Palatable oral veterinary compositions
    Patent number: 11020350
    Abstract: The present invention concerns palatable veterinary compositions made from one or more pharmaceutical active ingredients having a smell and/or a taste that is repulsive to animals, and a preparation method for preparing said oral veterinary compositions.
    Type: Grant
    Filed: June 1, 2013
    Date of Patent: June 1, 2021
    Assignee: Ceva Santé Animale
    Inventors: Laurence Peyrot, Florence Guimberteau
  • Multivalent recombinant SPV
    Patent number: 11020472
    Abstract: The present invention relates to novel recombinant swinepox viruses and their use in vaccine compositions. The recombinant swinepox viruses of the invention are doubly defective for IL18bp and TK genes, and comprise at least one foreign gene cloned into defective TK gene sequence. The invention is particularly suited to produce swine vaccines, particularly for vaccinating swine against PCV2 infection.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: June 1, 2021
    Assignee: CEVA SANTE ANIMALE
    Inventors: Takanori Sato, Shuji Saitoh, Yasutoshi Komiya
  • Methods for controlling the spread of dirofilariosis
    Patent number: 10952988
    Abstract: This invention relates to a method of controlling the spread of dirofilariosis, such as for example heartworm, by administering to at least one non-human animal infested with filarioid nematodes such as Dirofilaria spp or susceptible to have been infested with filarioid nematodes such as Dirofilaria spp, an effective dose of a combination of a neonicotinoid compound and a pyrethroid compound.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: March 23, 2021
    Assignee: Ceva Santé Animale
    Inventors: Marie Varloud, Elizabeth Hodgkins
  • VACCINE COMPOSITION AGAINST STREPTOCOCCUS SUIS INFECTION
    Publication number: 20210015910
    Abstract: Described is a vaccine composition comprising an effective amount of at least one polypeptide selected from the group of IdeSsuis, rldeSsuis, an analogue or a fragment thereof, or a polynucleotide encoding the same. This vaccine composition is used in the prophylactic, metaphylactic or therapeutic treatment of a Streptococcus suis infections in pigs or humans.
    Type: Application
    Filed: August 5, 2020
    Publication date: January 21, 2021
    Applicant: Ceva Santé Animale S.A.
    Inventors: Jana Seele, Christoph Baums, Peter Valentin-Weigand
  • Duck Enteritis Virus and the uses thereof
    Patent number: 10821170
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: November 3, 2020
    Assignee: CEVA SANTE ANIMALE
    Inventors: Saeki Yukari, Shuji Saitoh
  • Duck enteritis virus and the uses thereof
    Patent number: 10717967
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: July 21, 2020
    Assignee: CEVA SANTE ANIMALE
    Inventors: Saeki Yukari, Shuji Saitoh
  • Duck Enteritis Virus and the uses thereof
    Patent number: 10711254
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: July 14, 2020
    Assignee: CEVA SANTE ANIMALE
    Inventors: Saeki Yukari, Shuji Saitoh
  • Duck enteritis virus and the uses thereof
    Patent number: 10711255
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: July 14, 2020
    Assignee: CEVA SANTE ANIMALE
    Inventors: Saeki Yukari, Shuji Saitoh
  • Duck enteritis virus and the uses thereof
    Patent number: 10704028
    Abstract: The present invention relates to DEV and the uses thereof. The invention is particularly suited to vaccinate poultry against avian pathogens.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: July 7, 2020
    Assignee: CEVA SANTE ANIMALE
    Inventors: Saeki Yukari, Shuji Saitoh
  • COMPOSITIONS AND USES THEREOF FOR CONTROLLING ECTOPARASITES IN NON-HUMAN MAMMALS
    Publication number: 20200163339
    Abstract: The invention relates to novel veterinary compositions comprising an effective amount of a neonicotinoid compound and an effective amount of a N-arylpyrazole compound. The invention also relates to the use of such compositions for controlling ectoparasites in a non-human mammal.
    Type: Application
    Filed: January 29, 2020
    Publication date: May 28, 2020
    Applicant: Ceva Santé Animale
    Inventors: Hamadi Karembe, Marie Varloud
  • PALATABLE ORAL VETERINARY COMPOSITIONS
    Publication number: 20200163891
    Abstract: The present invention concerns palatable veterinary compositions made from one or more pharmaceutical active ingredients having a smell and/or a taste that is repulsive to animals, and a preparation method for preparing said oral veterinary compositions.
    Type: Application
    Filed: January 29, 2020
    Publication date: May 28, 2020
    Applicant: Ceva Santé Animale
    Inventors: Laurence Peyrot, Florence Guimberteau
  • Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
    Patent number: 10500270
    Abstract: The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein the at least two recombinant nucleotide sequences are inserted into distinct non-coding regions of the viral genome chosen among the region located between UL44 and UL45, the region located between UL45 and UL46, the region located between US10 and SORF3, and the region located between SORF3 and US2.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: December 10, 2019
    Assignee: CEVA SANTE ANIMALE
    Inventors: Ayumi Fujisawa, Mayumi Kubomura, Sakiko Saeki, Shuji Saito
  • Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
    Patent number: 10245315
    Abstract: The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein the at least two recombinant nucleotide sequences are inserted into distinct non-coding regions of the viral genome chosen among the region located between UL44 and UL45, the region located between UL45 and UL46, the region located between US10 and SORF3, and the region located between SORF3 and US2.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: April 2, 2019
    Assignee: CEVA SANTE ANIMALE
    Inventors: Ayumi Fujisawa, Mayumi Kubomura, Sakiko Saeki, Shuji Saito
  • Jug
    Patent number: D883104
    Type: Grant
    Filed: October 24, 2017
    Date of Patent: May 5, 2020
    Assignee: CEVA SANTÉ ANIMALE
    Inventor: Jean-François Castaing
  • Medallion
    Patent number: D936305
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: November 16, 2021
    Assignee: CEVA SANTE ANIMALE
    Inventor: Bénédicte Deminiere